ing drugs, as well as statistical information 
on the geographic areas of such seizures.’’; 
(5) in subsection (b)(2)(B), by striking ‘‘Pro-
gram’’ and inserting ‘‘Strategy’’; and 
(6) in subsection (c), by striking ‘‘in’’ and in-
serting ‘‘on’’. 
SEC. 105. BUDGETARY MATTERS. 
(a) SUBMISSION OF DRUG CONTROL BUDGET RE-
QUESTS.—Section 704(c)(1) is amended by adding at the 
end the following: 
‘‘(C) CONTENT OF DRUG CONTROL BUDG-
ET REQUESTS.—A drug control budget request 
submitted by a department, agency, or program 
under this paragraph shall include all requests 
for funds for any drug control activity under-
taken by that department, agency, or program, 
including demand reduction, supply reduction, 
and State, local, and tribal affairs, including 
any drug law enforcement activities. If an activ-
ity has both drug control and nondrug control 
purposes or applications, the department, agen-
cy, or program shall estimate by a documented 
calculation the total funds requested for that 
activity that would be used for drug control, 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00026
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
and shall set forth in its request the basis and 
method for making the estimate.’’. 
(b) NATIONAL
DRUG
CONTROL
BUDGET
PRO-
POSAL.— 
(1) 
NATIONAL
ORGANIZATIONS.—Section 
704(c)(2) is amended by inserting ‘‘and the head of 
each major national organization that represents law 
enforcement officers, agencies, or associations’’ after 
‘‘agency’’. 
(2) TOTAL BUDGET.—Section 704(c)(2)(A) is 
amended by inserting before the semicolon: ‘‘and to 
inform Congress and the public about the total 
amount proposed to be spent on all supply reduction, 
demand reduction, State, local, and tribal affairs, in-
cluding any drug law enforcement, and other drug 
control activities by the Federal Government, which 
shall conform to the content requirements set forth 
in paragraph (1)(C)’’. 
(c) REVIEW
AND CERTIFICATION
OF NATIONAL 
DRUG CONTROL PROGRAM BUDGET.—Section 704(c)(3) 
is amended— 
(1) by redesignating subparagraphs (C) and 
(D) as subparagraphs (D) and (E), respectively; 
(2) by inserting after subparagraph (B) the fol-
lowing new subparagraph: 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00027
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘(C) SPECIFIC REQUESTS.—The Director 
shall not confirm the adequacy of any budget 
request that— 
‘‘(i) requests funding for Federal law 
enforcement activities that do not ade-
quately compensate for transfers of drug 
enforcement resources and personnel to 
law enforcement and investigation activi-
ties; 
‘‘(ii) requests funding for law enforce-
ment activities on the borders of the 
United States that do not adequately di-
rect resources to drug interdiction and en-
forcement; 
‘‘(iii) requests funding for drug treat-
ment activities that do not provide ade-
quate results and accountability measures; 
‘‘(iv) requests funding for any activi-
ties of the Safe and Drug-Free Schools 
Program that do not include a clear anti- 
drug message or purpose intended to re-
duce drug use; 
‘‘(v) requests funding for drug treat-
ment activities that do not adequately sup-
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00028
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
port and enhance Federal drug treatment 
programs and capacity; 
‘‘(vi) requests funding for fiscal year 
2007 for activities of the Department of 
Education, unless it is accompanied by a 
report setting forth a plan for providing 
expedited consideration of student loan ap-
plications for all individuals who submitted 
an application for any Federal grant, loan, 
or work assistance that was rejected or de-
nied pursuant to 484(r)(1) of the Higher 
Education 
Act 
of 
1965 
(20 
U.S.C. 
1091(r)(1)) by reason of a conviction for a 
drug-related offense not occurring during a 
period of enrollment for which the indi-
vidual was receiving any Federal grant, 
loan, or work assistance; and 
‘‘(vii) requests funding for the oper-
ations and management of the Department 
of Homeland Security that does not in-
clude a specific request for funds for the 
Office of Counternarcotics Enforcement to 
carry out its responsibilities under section 
878 of the Homeland Security Act of 2002 
(6 U.S.C. 458).’’; 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00029
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
(3) in subparagraph (D)(iii), as so redesig-
nated, by inserting ‘‘and the appropriate congres-
sional committees’’ after ‘‘House of Representa-
tives’’; and 
(4) in subparagraph (E)(ii)(II)(bb), as so redes-
ignated, by inserting ‘‘and the appropriate congres-
sional committees’’ after ‘‘House of Representa-
tives’’. 
(d) REPROGRAMMING AND TRANSFER REQUESTS.— 
Section 704(c)(4)(A) (21 U.S.C. 1703(c)(4)(A)) is amend-
ed— 
(1) by striking ‘‘$5,000,000’’ and inserting 
‘‘$1,000,000’’; and 
(2) adding at the end the following: ‘‘If the Di-
rector has not responded to a request for reprogram-
ming subject to this subparagraph within 30 days 
after receiving notice of the request having been 
made, the request shall be deemed approved by the 
Director under this subparagraph and forwarded to 
Congress.’’. 
(e) POWERS
OF
DIRECTOR.—Section 704(d) is 
amended— 
(1) in paragraph (8)(D), by striking ‘‘have been 
authorized by Congress;’’ and inserting ‘‘authorized 
by law;’’; 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00030
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
(2) in paragraph (9), by striking ‘‘Strategy; 
and’’ and inserting ‘‘Strategy and notify the appro-
priate congressional committees of any fund control 
notice issued; and’’; and 
(3) in paragraph (10), by striking ‘‘(22 U.S.C. 
2291j).’’ and inserting ‘‘(22 U.S.C. 2291j) and sec-
tion 706 of the Foreign Relations Authorization Act, 
Fiscal Year 2003 (22 U.S.C. 2291j–1).’’. 
(f) FUND CONTROL NOTICES.—Section 704(f) (21 
U.S.C. 1703(f)) is amended by adding at the end the fol-
lowing: 
‘‘(4) CONGRESSIONAL NOTICE.—A copy of each 
fund control notice shall be transmitted to the ap-
propriate congressional committees. 
‘‘(5) RESTRICTIONS.—The Director shall not 
issue a fund control notice to direct that all or part 
of an amount appropriated to the National Drug 
Control Program agency account be obligated, modi-
fied, or altered in any manner contrary, in whole or 
in part, to a specific appropriation or statute.’’. 
TITLE II—THE NATIONAL DRUG 
CONTROL STRATEGY 
SEC. 201. ANNUAL PREPARATION AND SUBMISSION OF NA-
TIONAL DRUG CONTROL STRATEGY. 
Section 706 is amended to read as follows: 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00031
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 
AND ASSESSMENT OF NATIONAL DRUG CON-
TROL STRATEGY. 
‘‘(a) TIMING, CONTENTS, AND PROCESS FOR DEVEL-
OPMENT AND SUBMISSION OF NATIONAL DRUG CONTROL 
STRATEGY.— 
‘‘(1) TIMING.—Not later than February 1 of 
each year, the President shall submit to Congress a 
National Drug Control Strategy, which shall set 
forth a comprehensive plan for the year to reduce il-
licit drug use and the consequences of such illicit 
drug use in the United States by limiting the avail-
ability of, and reducing the demand for, illegal 
drugs. 
‘‘(2) CONTENTS.— 
‘‘(A) IN
GENERAL.—The National Drug 
Control Strategy submitted under paragraph 
(1) shall include the following: 
‘‘(i) Comprehensive, research-based, 
long-range, quantifiable goals for reducing 
illicit drug use and the consequences of il-
licit drug use in the United States. 
‘‘(ii) Annual quantifiable and measur-
able objectives and specific targets to ac-
complish long-term quantifiable goals that 
the Director determines may be achieved 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00032
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
during each year beginning on the date on 
which the National Drug Control Strategy 
is submitted. 
‘‘(iii) A 5-year projection for program 
and budget priorities. 
‘‘(iv) A review of international, State, 
local, and private sector drug control ac-
tivities to ensure that the United States 
pursues coordinated and effective drug 
control at all levels of government. 
‘‘(v) An assessment of current illicit 
drug use (including inhalants and steroids) 
and availability, impact of illicit drug use, 
and treatment availability, which assess-
ment shall include— 
‘‘(I) estimates of drug prevalence 
and frequency of use as measured by 
national, State, and local surveys of il-
licit drug use and by other special 
studies of nondependent and depend-
ent illicit drug use; 
‘‘(II) illicit drug use in the work-
place and the productivity lost by such 
use; and 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00033
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘(III) 
illicit 
drug 
use 
by 
arrestees, probationers, and parolees. 
‘‘(vi) An assessment of the reduction 
of illicit drug availability, as measured 
by— 
‘‘(I) the quantities of cocaine, 
heroin, marijuana, methamphetamine, 
ecstasy, and other drugs available for 
consumption in the United States; 
‘‘(II) the amount of marijuana, 
cocaine, heroin, methamphetamine, ec-
stasy, and precursor chemicals and 
other drugs entering the United 
States; 
‘‘(III) the number of illicit drug 
manufacturing laboratories seized and 
destroyed and the number of hectares 
of marijuana, poppy, and coca cul-
tivated and destroyed domestically 
and in other countries; 
‘‘(IV) the number of metric tons 
of marijuana, heroin, cocaine, and 
methamphetamine seized and other 
drugs; and 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00034
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘(V) changes in the price and 
purity of heroin, methamphetamine, 
and cocaine, changes in the price of 
ecstasy, 
and 
changes 
in 
tetrahydrocannabinol level of mari-
juana and other drugs. 
‘‘(vii) An assessment of the reduction 
of the consequences of illicit drug use and 
availability, which shall include— 
‘‘(I) the burden illicit drug users 
placed on hospital emergency depart-
ments in the United States, such as 
the quantity of illicit drug-related 
services provided; 
‘‘(II) the annual national health 
care cost of illicit drug use; and 
‘‘(III) the extent of illicit drug- 
related crime and criminal activity. 
‘‘(viii) A determination of the status 
of drug treatment in the United States, by 
assessing— 
‘‘(I) public and private treatment 
utilization; and 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00035
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘(II) the number of illicit drug 
users the Director estimates meet di-
agnostic criteria for treatment. 
‘‘(ix) A review of the research agenda 
of the Counterdrug Technology Assessment 
Center to reduce the availability and abuse 
of drugs. 
‘‘(x) A summary of the efforts made 
to coordinate with private sector entities to 
conduct private research and development 
of medications to treat addiction by— 
‘‘(I) screening chemicals for po-
tential therapeutic value; 
‘‘(II) developing promising com-
pounds; 
‘‘(III) conducting clinical trials; 
‘‘(IV) seeking Food and Drug 
Administration approval for drugs to 
treat addiction; 
‘‘(V) marketing the drug for the 
treatment of addiction; 
‘‘(VI) urging physicians to use 
the drug in the treatment of addic-
tion; and 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00036
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘(VII) 
encouraging 
insurance 
companies to reimburse the cost of 
the drug for the treatment of addic-
tion. 
‘‘(xi) An assessment of Federal effec-
tiveness in achieving the National Drug 
Control Strategy for the previous year, in-
cluding a specific evaluation of whether the 
objectives and targets for reducing illicit 
drug use for the previous year were met 
and reasons for the success or failure of 
the previous year’s Strategy. 
‘‘(xii) A general review of the status 
of, and trends in, demand reduction activi-
ties by private sector entities and commu-
nity-based organizations, including faith- 
based organizations, to determine their ef-
fectiveness and the extent of cooperation, 
coordination, and mutual support between 
such entities and organizations and Fed-
eral, State, local, and tribal government 
agencies. 
‘‘(xiii) Such additional statistical data 
and information as the Director considers 
appropriate to demonstrate and assess 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00037
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
trends relating to illicit drug use, the ef-
fects and consequences of illicit drug use 
(including the effects on children of sub-
stance abusers), supply reduction, demand 
reduction, drug-related law enforcement, 
and the implementation of the National 
Drug Control Strategy. 
‘‘(xiv) A supplement reviewing the ac-
tivities of each individual National Drug 
Control Program agency during the pre-
vious year with respect to the National 
Drug Control Strategy and the Director’s 
assessment of the progress of each Na-
tional Drug Control Program agency in 
meeting its responsibilities under the Na-
tional Drug Control Strategy. 
‘‘(B) 
CLASSIFIED
INFORMATION.—Any 
contents of the National Drug Control Strategy 
that involve information properly classified 
under criteria established by an Executive order 
shall be presented to Congress separately from 
the rest of the National Drug Control Strategy. 
‘‘(C) SELECTION OF DATA AND INFORMA-
TION.—In selecting data and information for 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00038
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
inclusion under subparagraph (A), the Director 
shall ensure— 
‘‘(i) the inclusion of data and informa-
tion that will permit analysis of current 
trends against previously compiled data 
and information where the Director be-
lieves such analysis enhances long-term as-
sessment of the National Drug Control 
Strategy; and 
‘‘(ii) the inclusion of data and infor-
mation to permit a standardized and uni-
form assessment of the effectiveness of 
drug treatment programs in the United 
States. 
‘‘(3) PROCESS FOR DEVELOPMENT AND SUB-
MISSION.—In developing and effectively imple-
menting the National Drug Control Strategy, the 
Director— 
‘‘(A) shall consult with— 
‘‘(i) the heads of the National Drug 
Control Program agencies; 
‘‘(ii) Congress; 
‘‘(iii) State, local, and tribal officials; 
‘‘(iv) private citizens and organiza-
tions, including community and faith-based 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00039
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
organizations with experience and expertise 
in demand reduction; 
‘‘(v) private citizens and organizations 
with experience and expertise in supply re-
duction; and 
‘‘(vi) appropriate representatives of 
foreign governments; 
‘‘(B) in satisfying the requirements of sub-
paragraph (A), shall ensure, to the maximum 
extent possible, that State, local, and tribal offi-
cials and relevant private organizations commit 
to support and take steps to achieve the goals 
and objectives of the National Drug Control 
Strategy; 
‘‘(C) with the concurrence of the Attorney 
General, may require the El Paso Intelligence 
Center to undertake specific tasks or projects to 
support or implement the National Drug Con-
trol Strategy; and 
‘‘(D) with the concurrence of the Director 
of National Intelligence and the Attorney Gen-
eral, may request that the National Drug Intel-
ligence Center undertake specific tasks or 
projects to support or implement the National 
Drug Control Strategy. 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00040
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘(b) SUBMISSION
OF REVISED STRATEGY.—The 
President may submit to Congress a revised National 
Drug Control Strategy that meets the requirements of this 
section— 
‘‘(1) at any time, upon a determination of the 
President, in consultation with the Director, that the 
National Drug Control Strategy in effect is not suf-
ficiently effective; or 
‘‘(2) if a new President or Director takes of-
fice.’’. 
SEC. 202. PERFORMANCE MEASUREMENTS. 
Section 706 is amended by adding at the end the fol-
lowing: 
‘‘(c) PERFORMANCE MEASUREMENT SYSTEM.—Not 
later than February 1 of each year, the Director shall sub-
mit to Congress as part of the National Drug Control 
Strategy, a description of a national drug control perform-
ance measurement system, that— 
‘‘(1) develops 2-year and 5-year performance 
measures and targets for each National Drug Con-
trol Strategy goal and objective established for re-
ducing drug use, availability, and the consequences 
of drug use; 
‘‘(2) describes the sources of information and 
data that will be used for each performance measure 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00041
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
incorporated into the performance measurement sys-
tem; 
‘‘(3) identifies major programs and activities of 
the National Drug Control Program agencies that 
support the goals and annual objectives of the Na-
tional Drug Control Strategy; 
‘‘(4) evaluates the contribution of demand re-
duction and supply reduction activities as defined in 
section 702 implemented by each National Drug 
Control Program agency in support of the National 
Drug Control Strategy; 
‘‘(5) monitors consistency between the drug-re-
lated goals and objectives of the National Drug Con-
trol Program agencies and ensures that each agen-
cy’s goals and budgets support and are fully con-
sistent with the National Drug Control Strategy; 
and 
‘‘(6) coordinates the development and imple-
mentation of national drug control data collection 
and reporting systems to support policy formulation 
and performance measurement, including an assess-
ment of— 
‘‘(A) the quality of current drug use meas-
urement instruments and techniques to measure 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00042
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
supply reduction and demand reduction activi-
ties; 
‘‘(B) the adequacy of the coverage of exist-
ing national drug use measurement instruments 
and techniques to measure the illicit drug user 
population, and groups that are at risk for il-
licit drug use; 
‘‘(C) the adequacy of the coverage of exist-
ing national treatment outcome monitoring sys-
tems to measure the effectiveness of drug abuse 
treatment in reducing illicit drug use and crimi-
nal behavior during and after the completion of 
substance abuse treatment; and 
‘‘(D) the actions the Director shall take to 
correct any deficiencies and limitations identi-
fied pursuant to subparagraphs (A) and (B) of 
this subsection. 
‘‘(d) MODIFICATIONS.—A description of any modi-
fications made during the preceding year to the national 
drug performance measurement system described in sub-
section (c) shall be included in each report submitted 
under subsection (b).’’. 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00043
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
SEC. 203. ANNUAL REPORT REQUIREMENT. 
(a) IN GENERAL.—On or before February 1 of each 
year, the Director shall submit a report to Congress that 
describes— 
(1) the strategy of the national media campaign 
and whether specific objectives of the campaign were 
accomplished; 
(2) steps taken to ensure that the national 
media campaign operates in an effective and effi-
cient manner consistent with the overall strategy 
and focus of the campaign; 
(3) plans to purchase advertising time and 
space; 
(4) policies and practices implemented to ensure 
that Federal funds are used responsibly to purchase 
advertising time and space and eliminate the poten-
tial for waste, fraud, and abuse; 
(5) all contracts entered into with a corpora-
tion, partnership, or individual working on behalf of 
the national media campaign; 
(6) specific policies and steps implemented to 
ensure compliance with title IV of this Act; 
(7) steps taken to ensure that the national 
media campaign will secure, to the maximum extent 
possible, no cost matches of advertising time and 
space or in-kind contributions that are directly re-
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00044
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
lated to the campaign in accordance with title IV of 
this Act; and 
(8) a review and evaluation of the effectiveness 
of the national media campaign strategy for the past 
year. 
(b) AUDIT.—The Government Accountability Office 
shall, at a frequency of not less than once per year— 
(1) conduct and supervise an audit and inves-
tigation relating to the programs and operations of 
the— 
(A) Office; or 
(B) certain programs within the Office, in-
cluding— 
(i) the High Intensity Drug Traf-
ficking Areas Program; 
(ii) the Counterdrug Technology As-
sessment Center; or 
(iii) the National Youth Anti-drug 
Media Campaign; and 
(2) provide the Director and the appropriate 
congressional committees with a report containing 
an evaluation of and recommendations on the— 
(A) policies and activities of the programs 
and operations subject to the audit and inves-
tigation; 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00045
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
(B) economy, efficiency, and effectiveness 
in the administration of the reviewed programs 
and operations; and 
(C) policy or management changes needed 
to prevent and detect fraud and abuse in such 
programs and operations. 
TITLE III—HIGH INTENSITY 
DRUG TRAFFICKING AREAS 
SEC. 301. HIGH INTENSITY DRUG TRAFFICKING AREAS 
PROGRAM. 
Section 707 is amended to read as follows: 
‘‘SEC. 707. HIGH INTENSITY DRUG TRAFFICKING AREAS 
PROGRAM. 
‘‘(a) ESTABLISHMENT.— 
‘‘(1) IN GENERAL.—There is established in the 
Office a program to be known as the High Intensity 
Drug Trafficking Areas Program (in this section re-
ferred to as the ‘Program’). 
‘‘(2) PURPOSE.—The purpose of the Program 
is to reduce drug trafficking and drug production in 
the United States by— 
‘‘(A) facilitating cooperation among Fed-
eral, State, local, and tribal law enforcement 
agencies to share information and implement 
coordinated enforcement activities; 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00046
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘(B) enhancing law enforcement intel-
ligence sharing among Federal, State, local, and 
tribal law enforcement agencies; 
‘‘(C) providing reliable law enforcement in-
telligence to law enforcement agencies needed to 
design effective enforcement strategies and op-
erations; and 
‘‘(D) supporting coordinated law enforce-
ment strategies which maximize use of available 
resources to reduce the supply of illegal drugs 
in designated areas and in the United States as 
a whole. 
‘‘(b) DESIGNATION.— 
‘‘(1) IN GENERAL.—The Director, in consulta-
tion with the Attorney General, the Secretary of the 
Treasury, the Secretary of Homeland Security, 
heads of the National Drug Control Program agen-
cies, and the Governor of each applicable State, may 
designate any specified area of the United States as 
a high intensity drug trafficking area. 
‘‘(2) ACTIVITIES.—After making a designation 
under paragraph (1) and in order to provide Federal 
assistance to the area so designated, the Director 
may— 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00047
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘(A) obligate such sums as are appro-
priated for the Program; 
‘‘(B) direct the temporary reassignment of 
Federal personnel to such area, subject to the 
approval of the head of the department or agen-
cy that employs such personnel; 
‘‘(C) take any other action authorized 
under section 704 to provide increased Federal 
assistance to those areas; and 
‘‘(D) coordinate activities under this sec-
tion (specifically administrative, recordkeeping, 
and funds management activities) with State, 
local, and tribal officials. 
‘‘(c) PETITIONS FOR DESIGNATION.—The Director 
shall establish regulations under which a coalition of inter-
ested law enforcement agencies from an area may petition 
for designation as a high intensity drug trafficking area. 
Such regulations shall provide for a regular review by the 
Director of the petition, including a recommendation re-
garding the merit of the petition to the Director by a panel 
of qualified, independent experts. 
‘‘(d) FACTORS FOR CONSIDERATION.—In considering 
whether to designate an area under this section as a high 
intensity drug trafficking area, the Director shall consider, 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00048
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS